Support scale development. Bonus of 3 million yuan for the top 100 pharmaceutical enterprise(s) for the first time; Encourage market exploration. A subsidy of 100 thousand yuan for 1 million USD in annual export for the first time, and an extra subsidy of 50 thousand yuan for an extra of 100 thousand USD in annual export. Support promotion of new medicine R&D capabilities. A fund support of up to 3 million yuan for each；license. A fund support of up to 2 million yuan for redevelopment of drugs already in the market to incorporate new indications.